Marzieh Ramzani Farani
University of Tehran, Sharif University of Technology
Research areas: Materials Science · Biomaterials · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications
0000-0002-4184-5670
About
Dr. Marzieh Ramezani Farani is a nanobiomaterials chemist with a Ph.D. in Nanotechnology from the University of Tehran and extensive academic and industrial experience across Iran, Italy, South Korea, and the United Kingdom. Her research focuses on the design and development of advanced multifunctional nanomaterials for targeted drug delivery, cancer therapy, and regenerative medicine. She has authored over 50 peer-reviewed publications, serving as first or corresponding author in numerous leading journals, and has made notable contributions to nanomedicine and tissue engineering. Dr. Farani has held prestigious research fellowships from the National Research Foundation of Korea and has served as a senior researcher at Inha University. She is an active member of the editorial boards of several scientific journals and a reviewer for multiple high-impact publications. Her work is highly interdisciplinary, bridging nanotechnology, materials science, and biomedical engineering to address critical challenges in healthcare and translational medicine.
Employment
Employment history is unavailable.
Education
-
University of Tehran PhD in Nanotechnology2014 - 2019
-
Sharif University of Technology M.Sc. in Nanotechnology2012 - 2014
-
Sharif University of Technology B.Sc. in Chemistry2007 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (62)
- Circular RNAs in tumorigenesis: an insight into recent research in biogenesis and targeted tumor therapy Save
- Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research Save
- Light-controlled CRISPR–dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications Save
- Multifunctional Nano-Contrast Agent Carriers: From Traditional Platforms to Next-Generation Theranostic Applications in Molecular Imaging Save
- Engineering ER-stress–driven immunogenic cell death with nanomedicine: UPR-axis control, DAMP signaling, and clinical translation Save
- Stimuli-responsive nanodiamonds for precision pharmacokinetics, pharmacodynamics, and drug delivery applications Save
- Programmable lipid nanoparticles for RNA therapeutics: Design principles and clinical translation Save
- In-vitro evaluation of the sealing capability of a novel cone-morse connection under dynamic loading. Save
- Biocompatibility and immunomodulation of MXenes for targeted delivery of bioactive agents and drugs Save
- Self-assembling nanocomposites for smart drug delivery: towards personalized and stimuli-responsive therapeutics Save
- Advancements in Nanomedicine for Allergic Diseases: Diagnosis, Toxicity, and Therapeutic Strategies Save
- Biomimetic Carbon‐Based Nanomaterials: From Design Strategies to Next‐Generation Biosensing and Theranostic Applications Save
- Drug-induced regeneration of pancreatic beta cells: An approach to cellular therapeutic targets Save
- Microbiome on a chip: a promising technology for modeling of human organ microbiomes and their interactions Save
- The role of the NcRNA/ferroptosis axis in lung cancer: molecular mechanisms and potential therapeutic targets Save
- State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment Save
- Circular RNA, A Molecule with Potential Chemistry and Applications in RNA-based Cancer Therapeutics: An Insight into Recent Advances Save
- Lipid-based nanomedicine for colorectal cancer: Progress and prospects Save
- Translating preclinical insights into clinical strategies: Targeting cancer stem cells and stemness in prostate cancer Save
- Graphene oxide-engineered chitosan nanoparticles: Synthesis, properties, and antibacterial activity for tissue engineering and regenerative medicine Save